Pizzo S V
Department of Pathology and Biochemistry, Duke University Medical Center, Durham, North Carolina.
Am J Med. 1989 Sep 11;87(3B):10S-14S. doi: 10.1016/0002-9343(89)80524-8.
Antithrombin III (ATIII) clearance from blood occurs by redistribution into the extravascular compartment and by binding to the endothelial surface. When, however, ATIII reacts with a proteinase such as alpha-thrombin, the complex is rapidly cleared from the circulation (half-life is approximately five minutes) by a receptor present on hepatocytes. This receptor binds a number of other serine proteinase inhibitors that are members of the class designated as the "serpins." ATIII, alpha 1-proteinase inhibitor, heparin cofactor II, and alpha 1-antichymotrypsin proteinase complexes bind to the same hepatic receptor, now designated as serpin receptor 1. Proteinase complexes with alpha 2-antiplasmin, another member of the serpin class, do not bind to serpin receptor 1. Recent studies suggest that the specificity of the receptor for serpins may reside in the so-called D helix (nomenclature based on the structure of alpha 1-proteinase inhibitor). The presence of ATIII on the surface of endothelial cells offers a unique mechanism for regulating proteinases formed during coagulation. Since this ATIII is probably associated with heparin-like substances and exists in a high-affinity state, the inhibitor rapidly binds proteinases such as alpha-thrombin. Once the complex forms, its affinity for heparinoids is decreased compared with ATIII, allowing the complex to dissociate from the endothelial surface for rapid clearance by the liver.
抗凝血酶III(ATIII)从血液中的清除是通过重新分布到血管外间隙以及与内皮表面结合来实现的。然而,当ATIII与诸如α-凝血酶之类的蛋白酶反应时,该复合物会通过肝细胞上存在的一种受体迅速从循环中清除(半衰期约为五分钟)。该受体可结合许多其他丝氨酸蛋白酶抑制剂,这些抑制剂属于被称为“丝氨酸蛋白酶抑制剂”(serpins)的类别。ATIII、α1-蛋白酶抑制剂、肝素辅因子II和α1-抗糜蛋白酶蛋白酶复合物都能与同一肝脏受体结合,该受体现在被称为丝氨酸蛋白酶抑制剂受体1。与丝氨酸蛋白酶抑制剂家族的另一个成员α2-抗纤溶酶形成的蛋白酶复合物则不与丝氨酸蛋白酶抑制剂受体1结合。最近的研究表明,该受体对丝氨酸蛋白酶抑制剂的特异性可能存在于所谓的D螺旋中(命名基于α1-蛋白酶抑制剂的结构)。内皮细胞表面的ATIII为调节凝血过程中形成的蛋白酶提供了一种独特的机制。由于这种ATIII可能与类肝素物质相关联并以高亲和力状态存在,因此该抑制剂能迅速结合诸如α-凝血酶之类的蛋白酶。一旦复合物形成,与ATIII相比,其对类肝素的亲和力会降低,从而使复合物从内皮表面解离,以便肝脏迅速清除。